Related Experiment Videos

Follow-up study of medication errors reported to the vaccine adverse event reporting system (VAERS)

Frederick Varricchio1, John Reed,

  • 1Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville MD, USA. Varricchio@comcast.net

Abstract

Insights

Medication errors reported in the Vaccine Adverse Event Reporting System (VAERS) were investigated. Most were not true errors, but data or reporter mistakes, though actual errors like wrong dosage were found.

Area of Science:

  • Pharmacovigilance
  • Medication Safety
  • Vaccine Reporting Systems

Background:

  • Apparent medication errors in the Vaccine Adverse Event Reporting System (VAERS) require investigation to determine their validity.
  • Understanding the source of misinformation in VAERS is crucial for improving data accuracy.

Purpose of the Study:

  • To ascertain if reported medication errors in VAERS are genuine.
  • To identify corrective actions for true errors and pinpoint the origin of misinformation for non-errors.

Main Methods:

  • Searched VAERS database for reports classified as 'error' or containing the word 'error' (July 2001-June 2002).
  • Investigated reports of vaccinations (MMR, DTP, DTaP, DTPH) administered outside recommended ages.

Main Results:

  • 119 potential errors identified; 102 (86%) were followed up.
  • 26 cases confirmed as actual medication errors.
  • 76 cases were not actual errors: 9 physician decisions, 37 data entry errors, 30 reporter errors.

Conclusions:

  • Actual medication errors included wrong inoculum, improper interval, wrong route, and overdose.
  • Many errors are preventable with increased attention to detail.
  • Preventive measures include barcoding, diverse manufacturers, and vial segregation to avoid confusion.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Vaccinations01:51

Vaccinations

Overview
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...